In the aforementioned experiment on Neuro2a cells, SCD5 also disturbed the activation of the canonical Wnt pathway [25] and the increased expression of SCD5 caused activation of the non-canonical Wnt pathway, in which GBM may intensify the dissemination of cancer cells [25]. Here, SCD5 is linked to glioblastoma.